Pages that link to "Q51620308"
Jump to navigation
Jump to search
The following pages link to Impaired glucose tolerance in the U.S. population (Q51620308):
Displaying 50 items.
- Impaired glucose tolerance (Q24655720) (← links)
- Effect of transcutaneous auricular vagus nerve stimulation on impaired glucose tolerance: a pilot randomized study (Q28242824) (← links)
- Pharmacoeconomics of diabetes surveillance and detection programmes (Q30664775) (← links)
- Troglitazone: a review of its use in the management of type 2 diabetes mellitus (Q33588554) (← links)
- The natural history of type 2 diabetes. Implications for clinical practice (Q33752751) (← links)
- Postprandial glucose: the nondiabetic state (Q34166404) (← links)
- Utility of hemoglobin A1c in predicting diabetes risk (Q34733790) (← links)
- Screening for diabetes in an outpatient clinic population (Q34742745) (← links)
- The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation (Q35001130) (← links)
- The epidemiology of atherosclerosis and its risk factors among Native Americans (Q35087594) (← links)
- Impaired glucose tolerance. (Q35170370) (← links)
- Diabetes in Aborigines and other Australian populations (Q35216496) (← links)
- Atypical antipsychotic agents and increased risk of diabetes: class action or differential action? (Q36040749) (← links)
- Use of glycated hemoglobin (HbA(1C)) and impaired glucose tolerance in the screening of undiagnosed diabetes in the Malaysian population (Q36263875) (← links)
- Feline models of type 2 diabetes mellitus (Q36521109) (← links)
- Arterial hypertension in diabetes mellitus: from theory to clinical practice. (Q36766087) (← links)
- Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies (Q36839519) (← links)
- Oral antidiabetic drugs and regression from prediabetes to normoglycemia: a meta-analysis (Q37999768) (← links)
- Understanding type 2 diabetes: from genetics to epigenetics (Q38405367) (← links)
- Race and hypertension. What is clinically relevant? (Q39370448) (← links)
- Insulin resistance and risk factors for coronary heart disease (Q40812885) (← links)
- Advances in the treatment of diabetes mellitus in the elderly. Development of insulin analogues (Q41277375) (← links)
- Strategies for preventing type II diabetes. What can be done to stem the epidemic? (Q41329650) (← links)
- Epidemiology of non-insulin-dependent diabetes mellitus and its macrovascular complications. A basis for the development of cost-effective programs (Q41388533) (← links)
- Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus (Q41734634) (← links)
- Does atherosclerosis contribute the development of Fahr's Syndrome? (Q42122498) (← links)
- Diabetes mellitus in schizophrenic patients (Q43600057) (← links)
- Prevalence of diabetes and impaired glucose tolerance in adult hypopituitarism on low dose oral hydrocortisone replacement therapy (Q43622779) (← links)
- Watchwords for type-2 diabetes prevention in primary health care. The dilemma of the pre-diabetic status (Q43679775) (← links)
- Type 2 diabetes care: the role of insulin-sensitizing agents and practical implications for cardiovascular disease prevention (Q43979001) (← links)
- Diabetes mellitus in a subgroup of older Mexicans: prevalence, association with cardiovascular risk factors, functional and cognitive impairment, and mortality (Q44004670) (← links)
- C-Reactive Protein Is Independently Associated With Fasting Insulin in Nondiabetic Women (Q44401142) (← links)
- The impaired hyperglycemic peak as an additional indicator of Type 2 diabetes development is misdetected (Q44764003) (← links)
- A study of the effects of acarbose on glucose metabolism in patients predisposed to developing diabetes: the Dutch acarbose intervention study in persons with impaired glucose tolerance (DAISI). (Q44888857) (← links)
- High glycosylated hemoglobin levels increase the risk of progression to diabetes mellitus in subjects with glucose intolerance (Q45012033) (← links)
- Diabetic foot infection. Bacteriologic analysis of 141 patients (Q45217414) (← links)
- Lipoprotein(a) and coronary heart disease: Authors' reply. (Q46129432) (← links)
- Genetic architecture: the shape of the genetic contribution to human traits and disease (Q47579970) (← links)
- Hypertension and nephropathy in diabetes mellitus: what is inherited and what is acquired? (Q47612824) (← links)
- Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study (Q50546299) (← links)
- Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age (Q50921907) (← links)
- Risk factors for cardiovascular disease in individuals with diabetes. The Strong Heart Study (Q50994528) (← links)
- Adiponectin as predictor for diabetes among pre-diabetic groups (Q51345120) (← links)
- Determinants for the progression from impaired glucose tolerance to non-insulin-dependent diabetes mellitus (Q51567452) (← links)
- Insulin kinetics, insulin action, and muscle morphology in lean or slightly overweight persons with impaired glucose tolerance (Q51569047) (← links)
- The Fasting Hyperglycaemia Study: I. Subject identification and recruitment for a non-insulin-dependent diabetes prevention trial. (Q51572062) (← links)
- Cardiovascular risk factors prior to the development of non-insulin-dependent diabetes mellitus in persons with impaired glucose tolerance: the Hoorn Study (Q51572959) (← links)
- Oral glucose tolerance test in general practice--when is it worthwhile? (Q51592691) (← links)
- The cardiovascular dysmetabolic syndrome. (Q54128061) (← links)
- Cardiovascular risk factors and diseases precede oral hypoglycaemic therapy in patients with type 2 diabetes mellitus (Q57388763) (← links)